Biology and genetic diversity of SARS-CoV-2, the causative agent of COVID-19.
DOI:
https://doi.org/10.54139/salus.v25i3.127Keywords:
Coronavirus, Coronavirus, COVID-19, Variants, Mutations, Genomic surveillanceAbstract
The infection generated by SARS-CoV-2 has caused more than 200 million cases and 4.5 million deaths worldwide. SARS-CoV-2 has accumulated mutations that allow it to be classified into different lineages. Some of these lineages have been designated variants by the WHO: under monitoring (VUM), of interest (VOI), or of concern (VOC). Methodology. Different strategies for genomic surveillance of these SARS-CoV-2 variants have been described in each country. In Venezuela, the strategies include the amplification of a fragment of the spike, PCR-RFLP, and sequencing of the complete viral genome, which has allowed us to monitor the introduction of VOCs and VOIs to the country. Results. By October 2021, in Venezuela, the circulation of three VOCs, Alpha, Gamma, and Delta, and the two VOIs (Lambda and Mu) have been described. Globally, the Delta variant predominates in practically all continents except some Latin American countries, although it is estimated that it will soon prevail in the region as well. Discussion. The circulation of variants in the countries is a very dynamic process and Venezuela does not escape from this reality; therefore, it is important to continue genomic surveillance of this virus.
Downloads
References
Pujol FH, Zambrano JL, Jaspe R, Loureiro CL, Vizzi E, Liprandi F, et al. Biología y evolución del coronavirus causante de la COVID-19. Rev Soc Venezol Microbiol 2020; 40:63-70.
Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol 2020; 81:104260. https://doi.org/10.1016/j.meegid.2020.104260
O'Toole A, Scher E, Underwood A, Jackson B, Hill V, McCrone JT, Colquhoun R, Ruis C, Abu-Dahab K, Taylor B, Yeats C, Du Plessis L, Maloney D, Medd N, Attwood SW, Aanensen DM, Holmes EC, Pybus OG, Rambaut A. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evolution 2021. 7: en prensa. https://doi.org/10.1093/ve/veab064
Pujol FH, Esparza, J. COVID-19: virus, variantes y vacunas. Bol Acade Cienc Fis Matemat Natur 202; LXXXI: 1-10.
World Health Organization. Tracking SARS-CoV-2 variants. 2021. Disponible en: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
Altmann DM, Boyton RJ, Beale R. Immunity to SARS-CoV-2 variants of concern. Science 2021; 371(6534):1103-1104. https://doi.org/10.1126/science.abg7404
Winger A, Caspari T.The Spike of Concern-The Novel Variants of SARS-CoV-2. Viruses. 2021; 13(6):1002. https://doi.org/10.3390/v13061002
WHO. COVID-19 Weekly Epidemiological Update. Edition 58, published 21 September 2021.
Loureiro CL, Jaspe RC, D Angelo P, Zambrano JL, Rodriguez L, Alarcon V, et al. SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak. PLoS One. 2021; 16(2):e0247196.. https://doi.org/10.1371/journal.pone.0247196
Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182:812-827.e19. https://doi.org/10.1016/j.cell.2020.06.043 PMID: 32697968. Salus
Jaspe RC, Sulbaran Y, Loureiro CL, D Angelo P, Rodriguez L, Garzaro DJ, et al. Introduction and rapid dissemination of SARS-CoV-2 Gamma Variant of Concern in Venezuela. Infect Genet Evol. https://doi.org/10.1016/j.meegid.2021:105147.
Jaspe RC, Sulbaran Y, Loureiro CL, D Angelo P, Rodriguez L, Garzaro DJ, et al. Importance of mutations in amino acid 484 of the Spike protein of SARS-CoV-2: rapid detection by restriction enzyme analysis. Invest Clin 2021; 62(Suppl. 2): 18 - 26. https://doi.org/10.22209/IC.v62s2a02.
Jaspe RC, Sulbaran Y, Loureiro CL, D' Angelo P, Rodriguez L, Garzaro D, et al. A simple method for detection of mutations in amino acid 452 of the Spike protein of SARS-CoV-2 using restriction enzyme analysis. Invest. Clin. 62: https://doi.org/10.22209/IC.v62n4a07.
Bezerra MF, Machado LC, De Carvalho VDCV, Docena C, Brandão-Filho SP, Ayres CFJ, et al. A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern. Infect Genet Evol. 2021; 92:104910. https://doi.org/10.1016/j.meegid.2021.104910.
Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021:1-17. https://doi.org/10.1038/s41576-021-00408-x.
Wahid M, Jawed A, Mandal RK, Dailah HG, Janahi EM, Dhama K, et al. Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies. Eur Rev Med Pharmacol Sci. 2021; 25(18):5857-5864. https://doi:10.26355/eurrev_202109_26805.
Andreano E, Paciello I, Piccini G, Manganaro N, Pileri P, Hyseni I, et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021 Oct 20. https://doi.org/10.1038/s41586-021-04117-7.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
